Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Astellas Pharma, Inc
Press release submission
| Aug 20, 2021
Astellas Receives European Commission Approval for First-in-Class EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
Press release submission
| Nov 29, 2020
ASTELLAS: Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis
Trending
+
Pharmaceuticals
Patient Daily
| May 14, 2024
Pitt researchers discover molecular mechanism behind noise-induced hearing loss
+
Pharmaceuticals
Patient Daily
| May 13, 2024
Regular bicycling linked to lower prevalence of knee pain: Study
+
Pharmaceuticals
Patient Daily
| May 15, 2024
American Lung Association suggests measures for reducing summer heat and air pollution
+
Pharmaceuticals
Patient Daily
| May 14, 2024
Four physicians receive inaugural St. George Foundation Distinguished Physician Awards